DR
Therapeutic Areas
Proteomics International Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Promarker™D | Diabetic kidney disease (CKD) | Commercial |
| Promarker™Eso | Esophageal adenocarcinoma | Commercial |
| Promarker™Endo | Endometriosis | Late‑stage validation |
| OxiDx | Oxidative stress biomarkers | Pre‑clinical |